Angel Alsina

659 total citations
33 papers, 475 citations indexed

About

Angel Alsina is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Angel Alsina has authored 33 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 15 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Angel Alsina's work include Liver Disease and Transplantation (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Angel Alsina is often cited by papers focused on Liver Disease and Transplantation (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Organ Transplantation Techniques and Outcomes (13 papers). Angel Alsina collaborates with scholars based in United States, Taiwan and United Kingdom. Angel Alsina's co-authors include Nyingi Kemmer, Guy Neff, John P. Leone, Alexander S. Rosemurgy, Lorenzo Rossaro, David Hull, Robert T. Schweizer, Stanley A. Bartus, Marty T. Sellers and Catherine Frenette and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Angel Alsina

31 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angel Alsina United States 12 326 280 158 100 53 33 475
Takayuki Fukuhara Japan 14 254 0.8× 219 0.8× 134 0.8× 46 0.5× 51 1.0× 30 402
Saira Khaderi United States 13 323 1.0× 300 1.1× 119 0.8× 47 0.5× 63 1.2× 27 494
Giacomo Batignani Italy 14 253 0.8× 300 1.1× 294 1.9× 340 3.4× 28 0.5× 32 690
S. Raptis Greece 10 158 0.5× 98 0.3× 164 1.0× 99 1.0× 57 1.1× 26 436
Hyun Yang South Korea 14 238 0.7× 152 0.5× 67 0.4× 86 0.9× 65 1.2× 40 398
Shigeaki Takeda Japan 13 126 0.4× 131 0.5× 118 0.7× 108 1.1× 50 0.9× 35 443
Eduardo A. Rodríguez United States 11 158 0.5× 147 0.5× 141 0.9× 128 1.3× 45 0.8× 39 381
Naotaka Shimozato Japan 13 158 0.5× 177 0.6× 58 0.4× 26 0.3× 40 0.8× 34 342
Dennis Tønner Nielsen Denmark 11 220 0.7× 96 0.3× 198 1.3× 253 2.5× 40 0.8× 28 536
Takahide Yokoyama Japan 14 120 0.4× 159 0.6× 329 2.1× 192 1.9× 29 0.5× 36 502

Countries citing papers authored by Angel Alsina

Since Specialization
Citations

This map shows the geographic impact of Angel Alsina's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angel Alsina with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angel Alsina more than expected).

Fields of papers citing papers by Angel Alsina

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angel Alsina. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angel Alsina. The network helps show where Angel Alsina may publish in the future.

Co-authorship network of co-authors of Angel Alsina

This figure shows the co-authorship network connecting the top 25 collaborators of Angel Alsina. A scholar is included among the top collaborators of Angel Alsina based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angel Alsina. Angel Alsina is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chaput, Dale, Rachel Sinkey, Amanda Garces, et al.. (2024). Proteomic studies of VEGFR2 in human placentas reveal protein associations with preeclampsia, diabetes, gravidity, and labor. Cell Communication and Signaling. 22(1). 221–221. 3 indexed citations
2.
Flamm, Steven L., Eric Lawitz, Brian B. Borg, et al.. (2023). Efficacy and Safety of Sofosbuvir/Velpatasvir Plus Ribavirin in Patients with Hepatitis C Virus-Related Decompensated Cirrhosis. Viruses. 15(10). 2026–2026. 4 indexed citations
4.
Flamm, Steven L., Eric Lawitz, Brian B. Borg, et al.. (2019). THU-138-High efficacy and improvement in CPT class with sofosbuvir/velpatasvir plus ribavirin for 12 weeks in patients with CPT C decompensated cirrhosis. Journal of Hepatology. 70(1). e221–e222. 2 indexed citations
7.
Alsina, Angel, et al.. (2018). Outcomes of abdominal surgeries in cirrhotic patients performed by liver transplant surgeons: Are these safe?. The American Journal of Surgery. 216(3). 518–523. 3 indexed citations
9.
Alsina, Angel, et al.. (2016). Successful Liver Transplantation for Hyperammonemic Fibrolamellar Hepatocellular Carcinoma. ACG Case Reports Journal. 3(1). e106–e106. 9 indexed citations
10.
Lipka, Seth, Sajiv Sethi, Alexandra T. Strauss, et al.. (2015). Vascular Complications After Transarterial Chemoembolization in Orthotopic Liver Transplant Patients. The American Journal of Gastroenterology. 110. S906–S906. 2 indexed citations
11.
Alsina, Angel, et al.. (2014). Liver transplantation for hepatocellular carcinoma in Puerto Ricans: underutilization of a curative therapy.. PubMed. 33(4). 170–6. 4 indexed citations
12.
Trotter, James F., Mónica Grafals, & Angel Alsina. (2013). Early use of renal-sparing agents in liver transplantation: A closer look. Liver Transplantation. 19(8). 826–842. 13 indexed citations
13.
Kemmer, Nyingi, et al.. (2013). Nonalcoholic Fatty Liver Disease Epidemic and Its Implications for Liver Transplantation. Transplantation. 96(10). 860–862. 57 indexed citations
14.
Toomey, Paul, Sharona Ross, Jonathan M. Hernandez, et al.. (2013). Outcomes after transjugular intrahepatic portosystemic stent shunt: a “bridge” to nowhere. The American Journal of Surgery. 205(4). 441–446. 18 indexed citations
15.
Alsina, Angel, et al.. (2012). Epidemiology of Hepatocellular Carcinoma in Florida – Part I: A Statewide Report. SHILAP Revista de lepidopterología. 2 indexed citations
16.
Mathur, Abhishek, John P. Leone, Nyingi Kemmer, et al.. (2012). Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma. HPB. 15(7). 504–510. 66 indexed citations
17.
Le, Tien, et al.. (2010). Insertion of Intracranial Pressure Monitors in Fulminant Hepatic Failure Patients. Neurosurgery. 66(3). 455–458. 22 indexed citations
18.
Alsina, Angel, et al.. (2009). Outcome of liver transplantation in a Hispanic population: 100 liver transplants in Puerto Ricans.. PubMed. 28(4). 301–6. 3 indexed citations
19.
Torres, Esther A., et al.. (2004). Improving access to liver transplantation: the University of Puerto Rico experience.. PubMed. 23(3). 183–8. 2 indexed citations
20.
Alsina, Angel, et al.. (1990). Liver Transplant for Metastatic Neuroendocrine Tumor. Journal of Clinical Gastroenterology. 12(5). 533–537. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026